Vaccines produced by one of the drug companies embroiled in the recent vaccine scandal might be available. As a supplement for children who had previously taken substandard doses, since production has resumed, authorities said.
The Wuhan Institute of Biological Products, which was reported to have produced a batch of 400, 520 doses of substandard diphtheria, tetanus and whooping cough vaccines (DTaP) for infants, has passed an inspection and resumed production, according to the State Drug Administration.
Last year, the company, based in Wuhan, Hubei province, was linked to substandard DTaP vaccines along with Changchun Changsheng Bio - tech Co in Jilin province.
The 252, 600 doses of vaccine produced by Changchun Changsheng Bio - tech Co were all sold in Shandong province, with 215, 184 children being vaccinated, according to the Center for Disease Control and Prevention in Shandong.
Source: China Daily